Pharmacokinetic and Pharmacodynamic Assessments of the Dipeptidyl Peptidase-4 Inhibitor PHX1149: Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Studies in Healthy Subjects-Reference-Cited by-同舟云学术

Pharmacokinetic and Pharmacodynamic Assessments of the Dipeptidyl Peptidase-4 Inhibitor PHX1149: Double-Blind, Placebo-Controlled, Single- and Multiple-Dose Studies in Healthy Subjects

Published:2007-08 Issue:8 Volume:29 Page:1692-1705
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

O'Farrell A. Marie,van Vliet Andre,Abou Farha Khalid,Cherrington Julie M.,Campbell David A.,Li Xinqiang,Hanway Denise,Li Jianke,Guler Hans-Peter

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. Type 2 diabetes-Therapy with dipeptidyl peptidase IV inhibitors;Demuth;Biochem Biophys Acta,2005

2. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans;Hoist;Am J Physiol Endocrinol Metab,2004

3. Enhancing incretin action for the treatment of type 2 diabetes;Drucker;Diabetes Care,2003

4. Byetta (amylin) exenatide injection [product information] [PDR Electronic Library]. Available at: http://www.thomsonhc.com. Accessed July 27, 2007.

5. Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1;Riddle;Diabetes Care,2006

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellulose supported TiO2/Cu2O for highly asymmetric conjugate addition of α,β-unsaturated compounds in aqueous phase;International Journal of Biological Macromolecules;2024-05

2. The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology;Chemical Reviews;2024-02-21

3. Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use;Pharmacy & Pharmacology;2023-04-28

4. Cellulosic CuI Nanoparticles as a Heterogeneous, Recyclable Catalyst for the Borylation of α,β-Unsaturated Acceptors in Aqueous Media;Catalysis Letters;2021-03-01

5. Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial;British Journal of Clinical Pharmacology;2020-02-11